Multiple companies publish Q3 2026 earnings call materials and transcripts, covering business performance updates across biotherapeutics, pharmaceuticals, and networking technology.
Arcutis Biotherapeutics, Ariston Holding, and Ardelyx each release earnings call transcripts, with coverage focused on management’s discussion of quarter results and related business developments. Ardelyx’s Q3 update is also described by Investing.com, which highlights that the company tops its growth goals and that the stock rises following the announcement. Seeking Alpha’s write-ups for Ardelyx include both the earnings call transcript and additional results materials.
Arista Networks also publishes an earnings call transcript, shifting the coverage from healthcare to enterprise networking. Across outlets, the shared angle is the companies’ own reported results and commentary during earnings calls, with Investing.com foregrounding performance against growth targets and market reaction, while Seeking Alpha presents transcript-based reporting and, in Ardelyx’s case, additional presentation material.
